SCHEMBL3162603

SCHEMBL3162603

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3cccc(C)c3)C(C)C2)nc(-c2ccccc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.48
▸ MAPT P10636 11/20 0.48
▸ KDM4E B2RXH2 4/20 0.48
▸ LMNA P02545 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ HTT P42858 2/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ GFER P55789 1/20 0.43
▸ TP53 P04637 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3165629 0.93 GSK3B (0.40) GSK3BMAPTKDM4ELMNAALDH1A1
SCHEMBL3169880 0.87 ADORA3 (0.46) MAPTKDM4ELMNAALDH1A1SMN1; SMN2
SCHEMBL3165370 0.86 GFER (0.47) GSK3BMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL3162425 0.82 EGFR (0.53) MAPTKDM4ELMNAALDH1A1SMN1; SMN2
SCHEMBL3171920 0.80 ADORA1 (0.47) GSK3BKDM4EALDH1A1
SCHEMBL3170234 0.80 ADORA1 (0.42) ALDH1A1HSD17B10MAPK1CYP1A2CYP3A4
SCHEMBL3170239 0.80 ADORA1 (0.42) ALDH1A1HSD17B10MAPK1CYP1A2CYP3A4
SCHEMBL3164831 0.79 MAPT (0.50) MAPTKDM4ELMNAALDH1A1SMN1; SMN2
SCHEMBL3163144 0.79 ADORA3 (0.46) MAPTKDM4ELMNAALDH1A1SMN1; SMN2
SCHEMBL3163125 0.79 NPC1 (0.47) GSK3BMAPTKDM4EALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback